Epidemiological studies reveal that IGF‐1 is multifaceted and critical in aging and age‐related diseases, including cardiovascular disease (Higashi et al. 2019), type 2 diabetes (Biadgo et al. 2020), and frailty (Doi et al. 2018). Here, IGF1 is linked to cardiovascular disorder.